October 26, 2008 May 26, 2008 May 28, 2008 February 27, 2008 March 23, 2007
February 9, 2007 January 18, 2007 December 20, 2006
|
MuriGen restructures G-CSF antagonist program with CSLNEW CANCER TARGET IDENTIFIEDRESEARCHERS AT WEHI PINPOINT THE FUNCTION OF A POTENT CANCER GENE MURIGEN PARTNER ENTERS COLLABORATION AGREEMENT WITH ABBOTT MAJOR DISCOVERY RAISES PROSPECT OF BETTER PATIENT CARE BY IMPROVING PLATELET LIFE SPANMURIGEN PARTNER ENTERS COLLABORATION AGREEMENT WITH GENENTECHMURIGEN TO BENEFIT FROM $32.55 MILLION FEDERAL GOVERNMENT GRANT MURIGEN THERAPEUTICS ANNOUNCES INVESTMENT BY STARFISH VENTURES
|
|---|
|
|
|||||||||||
|
|
|
|
|||||||||
![]() |
|||||||||||
|
|
|
|
|
|
|
|
|
|
|||
|
|
|||||||||||
![]() |
![]() |
||||||||||
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|